The Pot Report. Get the Report
The week in cannabis, in five minutes.Free, every week, from The Pot Report.
Get the Report

Author: <span>thepotreport</span>

Products · Illinois, Kentucky · November 13, 2026

I Found Weed’s Answer to Light Beer. Congress Says It’s Too Strong.

A low-dose THC beer called Herb Light, from Chicago ad agency Quality Meats, packs 1 mg of THC and 1 mg of CBD per can. It is a hemp-derived low-dose THC beer that a High Times writer tried in Kentucky. But a federal hemp rewrite signed in November 2025 caps finished products at 0.4 mg THC per container from Dec. 11, and Illinois moves first.

Why it matters: The lightest THC drink on the shelf may soon be too strong to sell as hemp. Shoppers who want a gentle, sessionable buzz could lose store and restaurant access. In Illinois, they would have to visit a dispensary. Low-dose drinkers may find fewer options, while higher-dose products stay available only through licensed cannabis channels.

Read moreSource: High Times

Medical · November 13, 2026

Brazil’s Medical Cannabis Market Reaches $90 Million A Year as Prescriptions Surge

Brazil's medical cannabis market is booming, according to consulting firm Close-Up International. Sales hit about US$90 million in the 12 months to August 2026, up 15% on the prior year and more than four times the August 2022 level. Pharmacy sales volume rose 31%, prescriptions climbed 37.9%, and unit prices fell roughly 11%.

Why it matters: Brazil is a US-adjacent signal of where regulated medical markets head: more prescribers, more competition from big drugmakers and cheaper products. Patients there gain from falling unit prices, but doctor turnover and import dependence show access is still uneven. New domestic cultivation rules could shift supply, though strict oversight remains in place.

Read moreSource: High Times

Laws · Wisconsin · November 13, 2026

Incoming Wisconsin Governor Says Marijuana Legalization Can Offset Medicaid Cuts, As Top Lawmaker Calls It A 2027 ‘Priority’

Wisconsin marijuana legalization is moving up the agenda. Governor-elect David Crowley (D) told CNN he wants cannabis revenue to help offset federal Medicaid cuts. Assembly Speaker-elect Greta Neubauer (D) called legalization a priority and said Democrats hope to pass it in the coming year, though budget versus standalone bill is undecided.

Why it matters: Democrats will hold the governor's office and both chambers in January, removing the Republican roadblock that has stalled legalization for years. For Wisconsin consumers, that makes legal access a realistic prospect rather than a talking point, though timing, bill format and final rules remain unsettled, and possession stays a crime until a law passes.

Read moreSource: Marijuana Moment

Laws · Illinois, Missouri · November 13, 2026

First Phase Of Renewed Federal Hemp Product Ban Takes Effect As Industry Pushes Congress For Regulatory Alternative

A federal hemp ban has begun its first phase, with hemp products made from synthetic cannabinoids no longer legal to produce or sell as of Thursday. A wider ban on hemp THC products is set for December 11. Lawmakers and industry groups are pushing Congress for regulation instead.

Why it matters: Most hemp THC products stay on shelves for now, since the first phase targets cannabinoids the plant cannot naturally make. Disagreement over which items are covered, such as HHC, leaves some products in a gray area. Whether Congress passes rules before December 11 will decide if hemp THC drinks and similar products survive.

Read moreSource: Marijuana Moment

Laws · North Carolina · November 13, 2026

Lawyer calls potential hemp rules a ‘doomsday scenario’ for businesses, discusses lawsuits

A looming federal hemp crackdown has Asheville shop owners worried. Rush N Relax Cannabis opened about a month ago selling hemp-derived THC products. Attorney Rod Kight calls the potential federal restrictions a "doomsday scenario" for hemp businesses, but says firms that invested and hired under current rules might sue. State Sen. Julie Mayfield wants age limits, labeling and testing.

Why it matters: If federal rules make many hemp-derived THC products illegal, shoppers in North Carolina could see familiar gummies and other items vanish from store shelves. Lawsuits could delay that, but nothing is settled. Lawmakers pushing age limits, labeling and testing signal that buyers may eventually get clearer THC information, though the timing and form remain unclear.

Read moreSource: wlos.com

Laws · Michigan, Wisconsin · November 13, 2026

Menominee issues 3 new dispensary licenses; Puff eyes opening next month

Menominee dispensary licenses are now being issued after voters raised the city's cap from nine to 13, with about 60% backing the change. Three new licenses went to High Wire Farms, Urb Cannabis and Puff Cannabis. Each comes with a no-lawsuit agreement ending litigation with the city. Puff is targeting an opening next month.

Why it matters: Menominee sits just across the line from Wisconsin, where marijuana is illegal, so more stores means more nearby options for cross-border buyers. The mayor expects the market to shrink if Wisconsin legalizes, which could mean fewer shops later. For now, the end of lawsuits removes a source of uncertainty about whether new stores can open.

Read moreSource: fox11online.com

The week in cannabis, in five minutes.Free, every week, from The Pot Report.
Get the Report
Laws · New Jersey, Texas, Wisconsin · November 13, 2026

Partial federal hemp product ban takes effect (Newsletter: November 13, 2026)

The first phase of the federal hemp product ban took effect, hitting cannabinoids that a Cannabis sativa L. plant cannot naturally produce. Marijuana Moment's newsletter says there is disagreement over exactly which products are covered. Other items the same day: Wisconsin's governor-elect backed legalization, and New Jersey's governor signed a bill aligning state hemp law with federal policy.

Why it matters: Shoppers who buy hemp-derived products may see shelves change as the federal hemp product ban begins with synthetic-type cannabinoids. The dispute over which products count means a product's legal status may stay unclear for a while. Meanwhile, state action on hemp THC, from New Jersey to Texas, shows rules are still shifting.

Read moreSource: Marijuana Moment

Laws · Pennsylvania, Virginia · November 13, 2026

Almost Every GOP Lawmaker That Trump-Linked PAC Supported With Marijuana Industry Donations Lost Their Election

Nearly every Republican in Congress backed with cannabis industry money through a Trump-linked PAC lost reelection in last week's midterms. Marijuana industry donations to the PAC, America First Agriculture Action, helped fund more than $4 million in ads and mailers for tough-race incumbents. One race remains uncalled, and the ads never mentioned cannabis.

Why it matters: The industry's money bought little electoral protection for the Republicans it helped, and several of those lawmakers have records against legalization. Consumers and patients should read this as a sign that donations alone do not guarantee friendlier votes. Congressional Republican leadership remains hostile to cannabis reform, even as the Trump administration pursues rescheduling.

Read moreSource: Marijuana Moment

Products · Colorado · November 12, 2026

What’s on your weed label? 86% of products lack required information | CU Boulder Today

Colorado cannabis labels are falling short, according to University of Colorado Boulder researchers. A secret shopper bought 480 products at 52 dispensaries, and only 14% carried every required label. Just 2% of flower products complied, versus 31% of concentrates. A follow-up test of 265 flower samples found only about half matched their stated THC content.

Why it matters: For Colorado shoppers, the number on a flower jar or pre-roll may not match what is inside, and pre-rolls made in dispensaries were the weakest. Missing storage and expiration details also leave buyers guessing about freshness. Concentrate potency looks more reliable. The findings may draw regulators' attention to labeling enforcement.

Read moreSource: colorado.edu

Medical · New York · November 12, 2026

Study: Patients Taking Medical Cannabis Are Twice as Likely To Discontinue Prescription Opioids

A study in the Journal of Addiction Medicine found medical cannabis patients were far likelier to quit prescription opioids. Researchers tracked 8,353 chronic pain patients on long-term opioid therapy for three months, with nearly 5,000 using authorized cannabis. Discontinuation ran two to three times higher among cannabis users, especially those on lower opioid doses.

Why it matters: The findings add to evidence that medical cannabis may help some chronic pain patients cut back on opioids, particularly those on lower doses. It does not show cannabis works for everyone or that stopping opioids is right for any individual. Patients and prescribers weighing options may see this as support for cannabis as an alternative therapy.

Read moreSource: NORML